炎性脱髓鞘病患者血清中白细胞介素 1β水平:MOG 抗体相关性疾病(MOGAD)的早期急性相明显上调。
Serum level of IL-1β in patients with inflammatory demyelinating disease: Marked upregulation in the early acute phase of MOG antibody associated disease (MOGAD).
机构信息
Department of Neurology, Seoul National University Hospital, Seoul, Republic of Korea; Department of Neurology, The Catholic University of Korea, Eunpyeong St. Mary's Hospital, Seoul, Republic of Korea; Department of Medicine, Graduate School, Kyung Hee University, Seoul, Republic of Korea.
Department of Neurology, Seoul National University College of Medicine, Neuroscience Research Institute, Seoul, Republic of Korea.
出版信息
J Neuroimmunol. 2020 Nov 15;348:577361. doi: 10.1016/j.jneuroim.2020.577361. Epub 2020 Aug 15.
BACKGROUND
To evaluate the serum cytokine profiles in patients with myelin oligodendrocyte glycoproteins antibody associated disease (MOGAD), compared to those in neuromyelitis optica spectrum disorder with aquaporin-4 immunoglobulin G (APQ4-IgG+ NMOSD), multiple sclerosis (MS), and other inflammatory demyelinating diseases (IDDs).
METHODS
The level of interleukin (IL)-1β, IL-5, IL-6, IL-10, IL-12p70, IL-17A, tumor necrosis factor (TNF)-α, and interferon (IFN)-γ in sera from 21 patients with MOGAD, 32 APQ4-IgG+ NMOSD, 24 MS, and 16 other IDDs were assessed.
RESULTS
In MOGAD patients, the levels of IL-1β and IL-12p70 were elevated compared to APQ4-IgG+ NMOSD. The level of IL-10 and the ratio of T helper (Th)-1/Th2-related cytokines were elevated in MOGAD patients compared to MS or other IDDs. In an intragroup analysis, the IL-1β was increased in acute stage of MOGAD, APQ4-IgG+ NMOSD, and also MS compared to their chronic stage counterpart. It was inversely correlated with time from acute attack to sampling in MOGAD (p < 0.001) and AQP4-IgG+ NMOSD (p = 0.001), but not in MS. Moreover, the IL-1β was most markedly upregulated in MOGAD sera sampled within 1 week from acute attack compared to those sampled after (p = 0.002).
CONCLUSIONS
The serum IL-1β can be elevated in the acute stage of patients with diverse IDDs including, MOGAD, APQ4-IgG+ NMOSD, and MS. This upregulation of serum IL-1β can be most markedly observed in the early acute stage of MOGAD patients. Further studies seem to be needed to determine the proper mechanism for the upregulation of serum IL-1β and also the role of IL-1β inhibition especially at the early acute stage of MOGAD.
背景
评估髓鞘少突胶质细胞糖蛋白抗体相关疾病(MOGAD)患者与水通道蛋白 4 免疫球蛋白 G(AQP4-IgG+)视神经脊髓炎谱系疾病(NMOSD)、多发性硬化症(MS)和其他炎症性脱髓鞘疾病(IDDs)患者的血清细胞因子谱。
方法
评估了 21 例 MOGAD 患者、32 例 AQP4-IgG+NMOSD、24 例 MS 和 16 例其他 IDDs 患者血清中白细胞介素(IL)-1β、IL-5、IL-6、IL-10、IL-12p70、IL-17A、肿瘤坏死因子(TNF)-α 和干扰素(IFN)-γ的水平。
结果
与 AQP4-IgG+NMOSD 相比,MOGAD 患者的 IL-1β 和 IL-12p70 水平升高。与 MS 或其他 IDDs 相比,MOGAD 患者的 IL-10 水平和 Th1/Th2 相关细胞因子的比值升高。在组内分析中,与慢性期相比,MOGAD、AQP4-IgG+NMOSD 和 MS 的急性期 IL-1β 增加。它与 MOGAD(p<0.001)和 AQP4-IgG+NMOSD(p=0.001)从急性发作到采样的时间呈负相关,但与 MS 无关。此外,与急性发作后(p=0.002)相比,MOGAD 患者急性发作后 1 周内采集的血清中 IL-1β 升高最为明显。
结论
包括 MOGAD、AQP4-IgG+NMOSD 和 MS 在内的多种 IDD 患者的急性期血清 IL-1β 可升高。在 MOGAD 患者的早期急性阶段,可观察到血清 IL-1β 的这种上调。需要进一步研究以确定血清 IL-1β 上调的适当机制,以及 IL-1β 抑制的作用,尤其是在 MOGAD 的早期急性阶段。